BioLife Solutions, Inc. (BLFS)
Makes chemicals and equipment that preserve and process cells for gene therapy manufacturing.
$32.46+0.09%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+56.0%
The outlook
BLFS is trading near the top of its 52-week range, well above both its 50- and 200-day moving averages, signaling upward momentum. Analyst sentiment leans bullish with a consensus "Buy" rating, though the average price target sits about 4% below the current price. The overall technical setup shows strength, but the stock is trading at an elevated level relative to recent analyst valuations.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Price targetAvg target -4% vs current price
Analyst price target
~12-month · 8 analysts$31.25average target-3.7% vs now
Now $32.46
Low $30.00High $33.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.59B
52-wk high
$33.12
52-wk low
$17.86
50-day avg
$26.81
200-day avg
$24.31
Trailing P/E
—